All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-YC1386 | Human anti-α/β-gliadin MM1 T cell receptor (B452), pCDTCR1 | Triticum aestivum | B452 | Human | SGQGSFQPSQQNP + DEAM(Q3, Q11) | HLA-DQA1*05:01/DQB1*03:02 | Lentiviral vector | |
TCR-YC1387 | Human anti-α/β-gliadin MM1 T cell receptor (B503), pCDTCR1 | Triticum aestivum | B503 | Human | SGQGSFQPSQQNP + DEAM(Q3, Q11) | HLA-DQA1*05:01/DQB1*03:02 | Lentiviral vector | |
TCR-YC1388 | Human anti-α/β-gliadin MM1 T cell receptor (Bel401), pCDTCR1 | Triticum aestivum | Bel401 | Human | SGQGSFQPSQQNP + DEAM(Q3, Q11) | HLA-DQA1*05:01/DQB1*03:02 | Lentiviral vector | |
TCR-YC1389 | Human anti-α/β-gliadin MM1 T cell receptor (Bel403), pCDTCR1 | Triticum aestivum | Bel403 | Human | SGQGSFQPSQQNP + DEAM(Q3, Q11) | HLA-DQA1*05:01/DQB1*03:02 | Lentiviral vector | |
TCR-YC1390 | Human anti-α/β-gliadin MM1 T cell receptor (Bel501), pCDTCR1 | Triticum aestivum | Bel501 | Human | SGQGSFQPSQQNP + DEAM(Q3, Q11) | HLA-DQA1*05:01/DQB1*03:02 | Lentiviral vector | |
TCR-YC1391 | Human anti-α/β-gliadin MM1 T cell receptor (C1401), pCDTCR1 | Triticum aestivum | C1401 | Human | SGQGSFQPSQQNP + DEAM(Q3, Q11) | HLA-DQA1*05:01/DQB1*03:02 | Lentiviral vector | |
TCR-YC1392 | Human anti-α/β-gliadin MM1 T cell receptor (C2501), pCDTCR1 | Triticum aestivum | C2501 | Human | SGQGSFQPSQQNP + DEAM(Q3, Q11) | HLA-DQA1*05:01/DQB1*03:02 | Lentiviral vector | |
TCR-YC1393 | Human anti-α/β-gliadin MM1 T cell receptor ((D2)-1), pCDTCR1 | Triticum aestivum | D2 | Human | LQPFPQPQLPYPQ + DEAM(Q8) | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC1394 | Human anti-α/β-gliadin MM1 T cell receptor ((D2)-2), pCDTCR1 | Triticum aestivum | D2 | Human | PFPQPQLPYPQPQ + DEAM(Q6) | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC1395 | Human anti-α/β-gliadin MM1 T cell receptor (E995), pCDTCR1 | Triticum aestivum | E995 | Human | SGQGSFQPSQQNP + DEAM(Q3, Q11) | HLA-DQA1*05:01/DQB1*03:02 | Lentiviral vector | |
TCR-YC1396 | Human anti-α/β-gliadin MM1 T cell receptor (JR5.1), pCDTCR1 | Triticum aestivum | JR5.1 | Human | PFPQPQLPYPQPQ + DEAM(Q6) | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC1397 | Human anti-α/β-gliadin MM1 T cell receptor (L3-12), pCDTCR1 | Triticum aestivum | L3-12 | Human | SGQGSFQPSQQNP + DEAM(Q3, Q11) | HLA-DQA1*05:01/DQB1*03:02 | Lentiviral vector | |
TCR-YC1398 | Human anti-α/β-gliadin MM1 T cell receptor (LS1.2), pCDTCR1 | Triticum aestivum | LS1.2 | Human | SGQGSFQPSQQNP + DEAM(Q3, Q11) | HLA-DQA1*05:01/DQB1*03:02 | Lentiviral vector | |
TCR-YC1399 | Human anti-α/β-gliadin MM1 T cell receptor (S13), pCDTCR1 | Triticum aestivum | S13 | Human | SGQGSFQPSQQNP + DEAM(Q3, Q11) | HLA-DQA1*05:01/DQB1*03:02 | Lentiviral vector | |
TCR-YC1400 | Human anti-α/β-gliadin MM1 T cell receptor ((S16)-1), pCDTCR1 | Triticum aestivum | S16 | Human | APQPELPYPQPGS | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC1403 | Human anti-α/β-gliadin MM1 T cell receptor (S2), pCDTCR1 | Triticum aestivum | S2 | Human | QPFPQPELPYPGS | HLA-DQ2.5 | Lentiviral vector | |
TCR-YC1404 | Human anti-α/β-gliadin MM1 T cell receptor (SP3.4), pCDTCR1 | Triticum aestivum | SP3.4 | Human | SGQGSFQPSQQNP + DEAM(Q3, Q11) | HLA-DQA1*05:01/DQB1*03:02 | Lentiviral vector | |
TCR-YC1405 | Human anti-α/β-gliadin MM1 T cell receptor (SP4.6), pCDTCR1 | Triticum aestivum | SP4.6 | Human | SGQGSFQPSQQNP + DEAM(Q3, Q11) | HLA-DQA1*05:01/DQB1*03:02 | Lentiviral vector | |
TCR-YC1406 | Human anti-α/β-gliadin MM1 T cell receptor (T316), pCDTCR1 | Triticum aestivum | T316 | Human | SGQGSFQPSQQNP + DEAM(Q3, Q11) | HLA-DQA1*05:01/DQB1*03:02 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION